DK0424351T3 - Anvendelse af modificeret heparin-cofaktor II - Google Patents

Anvendelse af modificeret heparin-cofaktor II

Info

Publication number: DK0424351T3
Authority: DK; Denmark
Prior art keywords: heparin cofactor; modified heparin; hcii; modified; cofactor
Prior art date: 1989-10-20

Application number

DK90870188.1T

Other languages

Danish (da)

English (en)

Inventor

Douglas Meyer Tollefsen

Vivianna Maia Derechin

Morey Alan Blinder

Original Assignee

Univ Washington

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-20

Filing date

1990-10-15

Publication date

1997-10-13

1990-10-15 Application filed by Univ Washington filed Critical Univ Washington

1997-10-13 Application granted granted Critical

1997-10-13 Publication of DK0424351T3 publication Critical patent/DK0424351T3/da

Links

HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 2
102000004032 Heparin Cofactor II Human genes 0.000 title abstract 2
108090000481 Heparin Cofactor II Proteins 0.000 title abstract 2
101100450563 Mus musculus Serpind1 gene Proteins 0.000 abstract 2
108090000190 Thrombin Proteins 0.000 abstract 1
239000004019 antithrombin Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
229960004072 thrombin Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)

DK90870188.1T 1989-10-20 1990-10-15 Anvendelse af modificeret heparin-cofaktor II DK0424351T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/424,440 US5102995A (en)	1989-10-20	1989-10-20	Dna encoding modified heparin cofactor ii

Publications (1)

Publication Number	Publication Date
DK0424351T3 true DK0424351T3 (da)	1997-10-13

Family

ID=23682642

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90870188.1T DK0424351T3 (da)	1989-10-20	1990-10-15	Anvendelse af modificeret heparin-cofaktor II

Country Status (9)

Country	Link
US (1)	US5102995A (fr)
EP (1)	EP0424351B1 (fr)
JP (1)	JPH03139280A (fr)
AT (1)	ATE154388T1 (fr)
CA (1)	CA2028082A1 (fr)
DE (1)	DE69030909T2 (fr)
DK (1)	DK0424351T3 (fr)
ES (1)	ES2104598T3 (fr)
GR (1)	GR3024588T3 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6291662B1 (en)	1984-12-05	2001-09-18	Amgen Inc.	Recombinant methods for production of serine protease inhibitors and DNA sequences
US5871956A (en) *	1984-12-06	1999-02-16	Amgen Inc.	Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US5900400A (en) *	1984-12-06	1999-05-04	Amgen Inc.	Serine protease inhibitor analogs
US6132990A (en) *	1984-12-06	2000-10-17	Amgen Boulder Inc.	Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
GB9024685D0 (en) *	1990-11-13	1991-01-02	Raleigh Industries Ltd	Cycle seat pillar mounting
JP3479539B2 (ja) *	1992-04-10	2003-12-15	エーザイ株式会社	ヒトアンチトロンビンｉｉｉ変異体
US6303691B1 (en)	1992-07-31	2001-10-16	Exxon Mobil Chemical Patents Inc.	Impact modification of polyamides
US6869925B1 (en) *	1992-09-09	2005-03-22	Amgen Inc.	Inhibition of retrovirus infection
US6017880A (en) *	1994-03-09	2000-01-25	Amgen Inc.	Inhibition of retrovirus infection
JPH09176040A (ja) *	1995-12-27	1997-07-08	Green Cross Corp:The	ヘパリンコファクターｉｉの医薬用途
AU2878199A (en) *	1998-02-27	1999-09-15	University Of North Carolina At Chapel Hill, The	Mutant heparin cofactor ii
AU2746399A (en) *	1998-03-09	1999-09-27	Welfide Corporation	Heparin cofactor ii-containing compositions and method for stabilizing the same
GB0916578D0 (en) *	2009-09-22	2009-10-28	Malmsten Nils M	Polypeptides and uses thereof
GB2500184A (en) *	2012-03-12	2013-09-18	Ximmune Ab	Polypeptide derived from helix A of heparin cofactor II
US20180078916A1 (en) *	2015-03-18	2018-03-22	Carnegie Mellon University	Lignin-based surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3521226A1 (de) *	1985-02-08	1986-08-14	Hoechst Ag, 6230 Frankfurt	Gene fuer biologisch aktive proteine
US4861865A (en) *	1989-01-23	1989-08-29	Washington University	Novel antithrombin peptide

1989
- 1989-10-20 US US07/424,440 patent/US5102995A/en not_active Expired - Fee Related
1990
- 1990-10-15 DE DE69030909T patent/DE69030909T2/de not_active Expired - Fee Related
- 1990-10-15 EP EP90870188A patent/EP0424351B1/fr not_active Expired - Lifetime
- 1990-10-15 DK DK90870188.1T patent/DK0424351T3/da active
- 1990-10-15 ES ES90870188T patent/ES2104598T3/es not_active Expired - Lifetime
- 1990-10-15 AT AT90870188T patent/ATE154388T1/de active
- 1990-10-19 CA CA002028082A patent/CA2028082A1/fr not_active Abandoned
- 1990-10-19 JP JP2279543A patent/JPH03139280A/ja active Pending
1997
- 1997-08-29 GR GR970402232T patent/GR3024588T3/el unknown

Also Published As

Publication number	Publication date
EP0424351B1 (fr)	1997-06-11
EP0424351A2 (fr)	1991-04-24
CA2028082A1 (fr)	1991-04-21
ES2104598T3 (es)	1997-10-16
ATE154388T1 (de)	1997-06-15
GR3024588T3 (en)	1997-12-31
EP0424351A3 (en)	1991-10-09
DE69030909T2 (de)	1998-01-29
JPH03139280A (ja)	1991-06-13
US5102995A (en)	1992-04-07
DE69030909D1 (de)	1997-07-17

Similar Documents

Publication	Publication Date	Title
DE69030909D1 (de)	1997-07-17	Verwendung von modifiziertem Heparin Kofaktor II
FI903331A0 (fi)	1990-07-02	Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
BR1100970A (pt)	1999-12-07	Composto, e, composição farmacêutica útil no tratamento de doença cardiovascular, tal como hipertensão e deficiência cardìaca congestiva
ES2078291T3 (es)	1995-12-16	Nuevos derivados de acido a-nor-esteroide-3-carboxilico.
AU3264489A (en)	1989-10-12	2-substituted-4-substituted-1,3-dioxalanes, synthesis and use thereof
DE3751742D1 (de)	1996-04-25	4,5,6-Substituierte 2-Pyrimidinamine
HUT77431A (hu)	1998-04-28	Fonálféregből kivont szerinproteáz-inhibitorok és véralvadásgátló proteinek
FR2388034A1 (fr)	1978-11-17	Adhesif du type a-cyanacrylate
FI92695B (fi)	1994-09-15	Uusi menetelmä heksa-, okta- tai dekahydronaftyylietyylisubstituoitujen 4-hydroksitetrahydropyran-2-onijohdannaisten valmistamiseksi
PT923554E (pt)	2002-07-31	N-benzilpiperidina e derivados tetrahidropiridina
ATE112558T1 (de)	1994-10-15	Glycosidasehemmer.
DE69805575D1 (de)	2002-07-04	Depolymerisation von Polyamiden
ATE90508T1 (de)	1993-07-15	Verwendung von di-styryl-phenyl-triglykolether als kristallisationsinhibitor.
DK270789A (da)	1989-12-05	Hirudin-derivater, deres fremstilling og anvendelse
KR910700089A (ko)	1991-03-13	히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
UA26435A (uk)	1999-08-30	Каталізатор полімеризації альфа-олефіhів, спосіб одержаhhя поліолефіhів з його використаhhям
DK0407212T3 (da)	1996-06-17	Enantioselektiv syntese af antifolater
DE69122376D1 (de)	1996-10-31	Hochreine Thrombinzubereitung
ES2060392T3 (es)	1994-11-16	Nueva region promotora.
ATE238791T1 (de)	2003-05-15	Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
MY104566A (en)	1994-04-30	Beta-lactam derivatives.
DK0618234T3 (da)	1997-08-25	Fremgangsmåde til fremstilling af semisyntetiske glycosaminoglycaner med heparin- eller heparanstruktur som er modificeret i 2-stillingen af alfa-L-iduron-2-O-sulfatsyren
MX9204642A (es)	1993-12-01	1,4-dihidropiridinas con actividad paf-antagonista
DE59406741D1 (de)	1998-09-24	Herzstückspitze
FI892289A0 (fi)	1989-05-11	Substituerade azoltioetrar, deras framstaellning och deras anvaendning som skadedjursbekaempningsmedel.